Day 1 Recap: 2024 Society for Pediatric Dermatology Annual Meeting

To stay informed with the latest conference insights, subscribe to receive our E-newsletters.

Q&A: Diagnostic and Therapeutic Pearls for Pediatric Dermatology

Mancini discusses his SPD 2024 lecture, emphasizing off-label treatments, surrogate diagnostic markers, simpler therapies, and the importance of empathy and education.

Nonthermal Atmospheric Plasma Deemed Safe, Efficacious in Pediatric Verruca Vulgaris and Molluscum Contagiosum

The average pain score reported during treatment was 0.4/10, according to a poster presented at the SPD's annual meeting.

Meena Julapalli, MD: Finding and Prioritizing Joy in the Pediatric Dermatology Specialty

Julapalli discusses her SPD 2024 lecture, "Rediscovering Joy in our Lives and the Workplace," excitement for the future of pediatric dermatology, and more.

Ixekizumab Yields Early, Sustained Improvements to Quality of Life Measures in Pediatric Patients With Plaque Psoriasis

All domains of the DLQI and CDLQI experienced improvements through 108 weeks, according to a poster presented at the SPD's annual meeting.

PODCAST: Navigating Artificial Intelligence in Medicine Featuring Albert Yan, MD, FAAP, FAAD

In this episode, Albert Yan, MD, FAAP, FAAD, discusses his SPD 2024 session revolving around the helpful (or hindering?) role of artificial intelligence and chatbots in dermatology.

HS in Children and Adolescents: Obesity-Related Treatment and Comorbidity Patterns

Hypertension and hyperlipidemia are common among obese pediatric patients with hidradenitis suppurativa, according to a poster presented at the SPD's annual meeting.

To view all conference coverage from SPD, click here.